If you have trouble reading this e-mail read the online version
ISSN : 2362-986X
European Commission EU eHealth in focus -
Newsletter
Researchers make progress on early detection of resistance to colorectal #cancer drugs
Researchers make progress on early detection of resistance to colorectal #cancer drugs
Mutations in a gene called KRAS are causally associated with acquired resistance to targeted therapies for colorectal cancers (CRC), according to new findings from EU-funded researchers from Italy and their research colleagues in the United States. Writing in the journal Nature, the team explain that patients often develop resistance to colorectal cancer drugs that target epidermal growth factor receptors (EGFRs).
See also : other EU-funded projects
This is the newsletter of the eHealth on Digital Agenda for Europe. It is hosted by the Digital Agenda for Europe Newsroom.

If this Newsletter was forwarded to you and you are interested to receive it directly you can subscribe here.

You may unsubscribe or broaden your subscription from this newsletter by going to Your Profile or by contacting us at this address: CNECT-EHEALTH@ec.europa.eu.